Talk to your doctor or nurse before you are given Phenytoin Injection if you suffer from or have suffered in the past from any of the following conditions:
- low blood pressure or heart failure
- disease of the liver or kidneys
- diabetes
- porphyria (an inherited condition affecting the nervous system and skin, characterised by abdominal pain, vomiting or muscle weakness)
- if you have drunk a large amount of alcohol recently or if you drink large amounts of alcohol regularly or if you have alcohol dependence
- potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of Phenytoin sodium, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin. The highest risk for occurrence of serious skin reactions is within the first weeks of treatment
- if you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of Phenytoin sodium, you must not be re-started on Phenytoin sodium at any time
- heart rhythm problems
- if you develop a rash or these skin symptoms, stop taking Phenytoin Injection, seek immediate advice from a doctor and tell that you are taking this medicine. Consult your doctor before discontinuing Phenytoin Injection. If you suddenly stop using this medicine you may have a seizure
- if you are of Taiwanese, Japanese, Malaysian or Thai origin and tests have shown that you carry the genetic variant CYP2C9*3.
The risk of these serious skin side effects may be associated with a variant in genes in a subject with Chinese or Thai origin. If you are of such origin and have been tested previously carrying this genetic variant (HLA-B* 1502), discuss this with your doctor before using Phenytoin Injection.
Black patients may be at greater risk of liver problems, serious skin reactions and allergic reactions. If you are taking phenytoin at the same time as you receive radiation therapy to your head and the dose of another medication called corticosteroids is reduced, you may more likely to develop a severe skin rash called erythema multiform or one that causes blistering called Stevens Johnson Syndrome or Toxic Epidermal Necrosis (see Possible Side Effects in section 4).
A small number of people being treated with anti-epileptics such as Phenytoin have had thoughts of harming or killing themselves, if at any time you have these thoughts, immediately contact your doctor. Tell your doctor if any of these apply to you as special care may be needed. Your doctor will take particular care with this medicine if you are elderly or gravely ill.
Phenytoin may precipitate or aggravate absence seizures and myoclonic seizures (two specific types of epilepsy).
There is a risk of harm to the unborn child if Phenytoin Injection is used during pregnancy. Women of childbearing age should use effective contraception during treatment with Phenytoin Injection (see Pregnancy and breast-feeding).
Pregnancy
What you should know about the use of antiepileptic drugs in pregnancy
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
If you are planning to become pregnant you should discuss your epilepsy treatment with your doctor as early as possible before you become pregnant. If you do get pregnant or think you may be pregnant while you are taking Phenytoin Injection, you must tell your doctor straight away and discuss possible risks the epilepsy medicine you are taking might pose to your unborn baby. You should not stop your treatment without discussing this with your doctor. Suddenly stopping may lead to breakthrough seizures which may harm you and your unborn baby. It is important that your epilepsy remains well controlled, but, as with other anti-epilepsy treatments, there is a risk of harm to the foetus.
Taking phenytoin during pregnancy increases the chance that the baby may have a physical birth abnormality.
Studies with women treated with phenytoin for epilepsy during pregnancy have shown that around babies in every 100 will have serious physical birth abnormalities. This compares to 2-3 babies in every 100 born to women who don’t have epilepsy.
The most common types of serious physical birth abnormalities (major congenital malformations) reported for phenytoin include abnormalities of the lip and palate, heart, skull, nail and finger disorders and growth abnormalities.
Taking more than one epilepsy medicine at the same time may also increase the risk of physical birth abnormalities. Where possible, your doctor will consider using one epilepsy medicine only to control your epilepsy.
Your doctor may advise you to take folic acid if you’re planning to become pregnant and while you’re pregnant. Your doctor may adjust your epilepsy medicine when you take folic acid.
Some studies observed that taking phenytoin during pregnancy increases the chance that the baby may have problems affecting learning and thinking abilities.
Make sure you are very clear about the risks and benefits of taking Phenytoin Injection.
Do not stop taking Phenytoin Injection until you have seen your doctor as it is important to control your fits. If given during pregnancy phenytoin may affect the baby but your doctor may decide that it is very important that you continue with phenytoin. He or she will explain the risks to you.
Phenytoin Injection can cause major birth defects. If you take Phenytoin Injection during pregnancy your baby has up to 3 times the risk of having a birth defect than women not taking an antiepileptic medication. Major birth defects including growth, skull, facial, nail, finger and heart abnormalities have been reported. Some of these may occur together as part of a fetal hydantoin syndrome.
Problems with neurodevelopment (development of the brain) have been reported in babies born to mothers who used phenytoin during pregnancy. Some studies have shown that phenytoin negatively affects neurodevelopment of children exposed to phenytoin in the womb, while other studies have not found such an effect. The possibility of an effect on neurodevelopment cannot be ruled out.
Breast-feeding
As phenytoin is released into breast milk, you should not breast-feed if you are being given this medicine.